INFORMATION:
Funding from the NIH/National Cancer Institute (grant CA150153) supported this research.
Other researchers involved in this study were Chelsea Bolyard, Ji Young Yoo, Jianying Zhang, Uksha Saini and Karuppaiyah Selvendiran, The Ohio State University; Pin-Yi Wang and Tim Cripe, Nationwide Children's Hospital; and Kellie S. Rath, Ohio Health Systems.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 228-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S.News & World Report. END
Cancer-killing virus plus chemotherapy drug might treat recurrent ovarian cancer
2014-11-13
(Press-News.org) COLUMBUS, Ohio - In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and effectively treat advanced or recurrent forms of the disease.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), led the cell and animal study. Reporting in the journal Clinical Cancer Research, the researchers showed that the oncolytic virus called 34.5ENVE has significant antitumor activity against ovarian cancer on its own, and that its activity is even greater when combined with the chemotherapy drug doxorubicin in an animal model of disseminated peritoneal ovarian cancer.
"Our findings suggest that this could be a promising therapy, and we believe it should be further developed for the treatment of recurrent or refractory ovarian cancer in humans," says principal investigator Balveen Kaur, PhD, professor of neurological surgery and an OSUCCC - James researcher.
Among women treated for ovarian cancer whose tumors regress, 70 percent experience recurrence. The recurrent tumors are thought to develop from reserves of cancer stem-like cells that are chemotherapy-resistant and survive therapy. Consequently, recurrent tumors also tend to be resistant to primary chemotherapy regimens, and lethal.
The oncolytic herpes simplex virus 34.5ENVE is engineered to target cancer cells that overexpress the protein nestin and to inhibit the growth of blood vessels to tumors.
The researchers chose to combine the oncolytic virus with doxorubicin because the drug is often administered to patients with recurrent ovarian cancer. "This study underscores the significance of combining the oncolytic virus with doxorubicin for patients who have developed resistance to primary chemotherapy," Kaur says.
Kaur and her colleagues assessed the anticancer activity of the oncolytic virus 34.5ENVE, which is a genetically engineered herpesvirus, using several ovarian cancer cell lines, human and mouse tumor cells, and an animal model. Key technical findings included:
The expression of nestin was 10 to 100 times greater in human ovarian tumor cells compared with normal ovarian cells;
In a model of disseminated peritoneal ovarian cancer, the combination of doxorubicin plus the oncolytic virus increased survival, with an average survival of 58 days for treated animals versus 32.5 days for controls;
The combination of doxorubicin and the oncolytic virus showed a synergistic increase in apoptosis (programmed cell death) in ovarian cancer cells compared to each agent alone.
ELSE PRESS RELEASES FROM THIS DATE:
Cold-induced pain linked to the garlic and mustard receptor
2014-11-13
Some people experience cold not only as feeling cold, but actually as a painful sensation. This applies even to fairly mild temperatures - anything below 20°C. A group of researchers from Lund University in Sweden have now identified the mechanism in the body that creates this connection between cold and pain. It turns out that it is the same receptor that reacts to the pungent substances in mustard and garlic.
Professor of Pharmacology Peter Zygmunt and Professor of Clinical Pharmacology Edward Högestätt have long conducted research on pain and the connection ...
Bigger is not always better
2014-11-13
For several years the Danish health service has been moving towards increased centralisation and specialisation in large hospital departments based on the thesis that this provides better results for patients. A new study involving more than 12,000 Danish patients with hip fractures presents a different picture, however:
"Our study shows that the mortality rate for this group of patients is lower in the smaller hospital departments compared to the larger departments. We can also see that the length of stay in hospital is shorter and the quality of care is generally better, ...
Switching on a dime: How plants function in shade and light
2014-11-13
Stanford, CA--Photosynthesis is the process by which plants convert energy from the sunlight into chemical energy in the form of sugars. These sugars are used by plants to grow and function, as well as food for animals and humans that eat them.
Plants grow in environments where the availability of light fluctuates quickly and drastically, for example from the shade of clouds passing overhead or of leaves on overhanging trees blowing in the wind. Plants thus have to rapidly adjust photosynthesis to maximize energy capture while preventing excess energy from causing damage. ...
Moms with rheumatoid arthritis more likely to give birth prematurely
2014-11-13
Researchers from Denmark and the U.S. report that babies of women with rheumatoid arthritis (RA) or pre-clinical RA--the period prior to symptoms--are 1.5 times more likely to be born prematurely in Denmark. Findings published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), indicate that body measurements of the baby at birth were only slightly lower in children exposed to maternal or preclinical RA compared to those with no exposure to the disease. Paternal RA was not found to impact fetal growth or preterm birth risk.
Roughly one ...
Did men evolve navigation skills to find mates?
2014-11-13
SALT LAKE CITY, Nov. 13, 2014 - A University of Utah study of two African tribes found evidence that men evolved better navigation ability than women because men with better spatial skills - the ability to mentally manipulate objects - can roam farther and have children with more mates.
By testing and interviewing dozens of members of the Twe and Tjimba tribes in northwest Namibia, the anthropologists showed that men who did better on a spatial task not only traveled farther than other men but also had children with more women, according to the study published this week ...
Pre-pregnancy body weight affects early development of human embryos
2014-11-13
New research indicates that the embryos of women who are overweight or obese at the time they conceive display distinct differences in early development compared to embryos from women of a healthy weight.
The results of the study, published today in the journal Human Reproduction, provide strong evidence for a direct link between what mothers eat and the ability of their fertilised eggs to divide and grow. The researchers claim this could potentially have long-term health implications for any children born from these embryos.
The four key findings of the study, which ...
Mongoose sentinels respond flexibly to threats
2014-11-13
Just as soldiers on sentry duty constantly adjust their behaviour to match the current threat level, dwarf mongoose sentinels exhibit flexible decision-making in relation to predation risk, new research from the University of Bristol has shown.
Biologists Julie Kern and Dr Andy Radford found that decisions about when to go on duty, what position to adopt and how long to remain on post were all affected by information about the likelihood of danger. Sentinels altered their behaviour depending on both environmental conditions, such as wind speed and social signals, such ...
Do homing pigeons navigate with gyroscope in brain?
2014-11-13
Human communication has long been associated with an unlikely companion, the homing pigeon; but how these pigeons find their way home is still largely a mystery. 'There is widespread agreement that pigeons are able to determine and maintain flight (compass) directions based on solar and magnetic cues,' says Hans-Peter Lipp from the University of Zurich, Switzerland, and Kwazulu-Natal University, South Africa. However, another piece of the puzzle - how the bird determines its position, known as the map sense - was unclear. Dissatisfied with the current theories - that pigeons ...
Climate change puts coastal crabs in survival mode, study finds
2014-11-13
SAN FRANCISCO, Nov. 12, 2014 -- Porcelain crabs can adapt to a warming climate but will not have energy for much else beyond basic survival, according to new research published today from San Francisco State University.
The findings have grim long-term implications for intertidal zone crabs as well as the myriad species that depend on them, and could be an indicator of how other intertidal organisms may respond to a rapidly changing climate.
The study is detailed in an article published in the Journal of Experimental Biology and is the first to explore intertidal zone ...
Prostate cancer researchers develop personalized genetic test to predict recurrence risk
2014-11-13
(TORONTO, Canada - Nov. 13, 2014) - Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.
The findings are published online today in Lancet Oncology. Study co-leads Dr. Robert Bristow, a clinician-scientist at Princess Margaret Cancer Centre, and Dr. Paul Boutros, an investigator at the Ontario Institute for Cancer Research, report that the gene test provides a much-needed quick and accurate tool to determine with greater precision ...